Amdocs director’s proposed sales valued at $245K, $314K
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amdocs Limited officer and director Shimie Hortig reported proposed sales of 5,642 ordinary shares, with an approximate sale date of November 14, 2026, and 7,255 ordinary shares, with an approximate sale date of November 15, 2026, through Morgan Stanley Smith Barney LLC. The respective aggregate market values are $244,502.10 and $314,403.18. The listed shares were acquired through vesting of restricted stock awards, with no consideration.
Key Figures
Key Terms
restricted stock award financial
Aggregate Market Value financial
Gross Proceeds financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.